NDAINJECTIONINJECTABLE
Approved
Feb 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
AMIODARONE HYDROCHLORIDE (amiodarone hydrochloride) by Medica Corp is drug, but it possesses electrophysiologic characteristics of all four vaughan williams classes. Approved for cardiac arrest, atrial fibrillation, ventricular tachycardia. First approved in 2004.
Drug data last refreshed 23h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Amiodarone hydrochloride is a multi-class antiarrhythmic agent with electrophysiologic properties spanning all four Vaughan-Williams classes, used to treat life-threatening cardiac arrhythmias including atrial fibrillation, ventricular tachycardia, and cardiac arrest. It works by blocking sodium, potassium, and calcium channels while exerting antisympathetic effects, prolonging cardiac action potential duration and refractory periods. The drug is administered via injection and has been approved since 2004.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30), likely indicating smaller team size and focus on defensive positioning rather than market expansion.
Mechanism of Action
drug, but it possesses electrophysiologic characteristics of all four Vaughan Williams classes. Like class I drugs, amiodarone blocks sodium channels at rapid pacing frequencies, and like class II drugs, amiodarone exerts a noncompetitive antisympathetic action. One of its main effects, with…
Worked on AMIODARONE HYDROCHLORIDE at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.